| Title |
Deferasirox for managing iron overload in people with thalassaemia
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, February 2012
|
| DOI | 10.1002/14651858.cd007476.pub2 |
| Pubmed ID | |
| Authors |
Meerpohl, Joerg J, Antes, Gerd, Rücker, Gerta, Fleeman, Nigel, Motschall, Edith, Niemeyer, Charlotte M, Bassler, Dirk |
| Abstract |
Thalassemia is a hereditary anaemia due to ineffective erythropoiesis. In particular, people with thalassaemia major develop secondary iron overload resulting from regular red blood cell transfusion. Iron chelation therapy is needed to prevent long-term complications.Both deferoxamine and deferiprone have been found to be efficacious. However, a systematic review of the effectiveness and safety of the new oral chelator deferasirox in people with thalassaemia is needed. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | 1% |
| France | 1 | 1% |
| Unknown | 90 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 16 | 17% |
| Researcher | 14 | 15% |
| Student > Bachelor | 12 | 13% |
| Student > Ph. D. Student | 10 | 11% |
| Student > Postgraduate | 9 | 10% |
| Other | 20 | 22% |
| Unknown | 11 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 49% |
| Nursing and Health Professions | 11 | 12% |
| Psychology | 5 | 5% |
| Agricultural and Biological Sciences | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 8 | 9% |
| Unknown | 17 | 18% |